Sleep Apnea vs Insomnia: Why the Difference Matters

Insomnia and obstructive sleep apnea are often discussed as if they are opposite problems: one means “I cannot sleep,” while the other means “I fall asleep but stop breathing.” Real sleep medicine is messier.

A person can have both. That overlap is commonly called COMISA, short for comorbid insomnia and sleep apnea. It matters because repeatedly adding sleep aids can be the wrong response when part of the problem is sleep-disordered breathing.

The basic distinction

Insomnia centers on difficulty initiating sleep, maintaining sleep, or waking too early despite adequate opportunity for sleep, together with daytime consequences.

Obstructive sleep apnea (OSA) involves repeated narrowing or closure of the upper airway during sleep, producing breathing disturbances, oxygen changes, arousals, and sleep fragmentation.

Those mechanisms are different, but the lived experience can overlap. Both can involve:

• repeated nighttime awakenings;
• unrefreshing sleep;
• fatigue or daytime sleepiness;
• concentration problems;
• irritability;
• long periods awake during the night.

That overlap is one reason “I keep waking up” is not enough information to select a supplement.

COMISA is not rare enough to ignore

Recent reviews increasingly treat COMISA as an important clinical phenotype rather than a curiosity. A 2026 systematic review and meta-analysis reported substantial overlap and found that people with COMISA can show worse sleep fragmentation and efficiency than comparison groups.

A 2025 clinical review likewise emphasized that insomnia and OSA can interact bidirectionally. Repeated respiratory events can promote hyperarousal and fragmented sleep, while chronic insomnia may complicate the experience and treatment of sleep apnea.

The practical lesson is simple: one diagnosis does not cancel out the other.

Why this matters for supplement content

Many sleep products are marketed around sedation or relaxation. That may make sense for certain symptoms, but sedation is not the same thing as correcting an obstructed airway.

Magnesium does not mechanically open the airway. Melatonin does not replace positive airway pressure. Valerian does not diagnose oxygen desaturation. A multi-herb stack does not rule out apneas.

That does not mean a person with OSA can never use a supplement for another reason. It means supplement benefit and disorder treatment are separate questions.

This distinction is particularly important when a product makes someone feel drowsier. Feeling easier to sedate can create the impression that the sleep problem is being solved even when breathing-related fragmentation remains.

What newer COMISA treatment evidence shows

A 2026 systematic review and network meta-analysis evaluated positive-airway-pressure-based combination therapies in COMISA. Across the available randomized evidence, combination approaches improved insomnia symptoms more than PAP alone, and sequencing CBT-I before PAP showed a consistent signal for improving daytime sleepiness.

The exact treatment plan belongs in clinical care, but the evidence reinforces a broader principle: when two sleep disorders coexist, both may need to be addressed. Treating only the airway may leave conditioned insomnia behind; treating only insomnia does not remove airway obstruction.

This also strengthens the case for CBT-I vs Sleep Supplements as a decision page. Persistent insomnia deserves a broader framework than escalating calming ingredients.

Clues that should move the question beyond supplements

No article can diagnose sleep apnea, and absence of a classic symptom does not rule it out. Still, sleep-disordered breathing becomes more important to evaluate when sleep complaints occur alongside features such as:

• loud or disruptive snoring;
• witnessed pauses, choking, or gasping during sleep;
• pronounced daytime sleepiness;
• morning headaches or dry mouth;
• resistant or difficult-to-control hypertension;
• repeated unexplained awakenings;
• a bed partner noticing abnormal breathing.

These are reasons for evaluation, not a home diagnostic checklist.

Insomnia can remain even after OSA is treated

Another mistake is assuming that once OSA is addressed, every insomnia symptom must disappear. COMISA research shows why that is not necessarily true. Learned wakefulness, anxiety about sleep, irregular schedules, or other insomnia-maintaining factors can persist.

That is where disorder-specific insomnia treatment such as CBT-I may still matter.

Bottom line

The high-value question is not “sleep apnea or insomnia?” as though only one can exist. The better question is which mechanisms are contributing to the sleep problem, and are we accidentally treating the wrong one?

For a supplement site, that is an important boundary. Sleep aids can be discussed honestly without implying that relaxation, sedation, or a higher sleep score substitutes for evaluation and treatment of obstructive sleep apnea.